Jinhe Biotechnology Balance Sheet Health
Financial Health criteria checks 3/6
Jinhe Biotechnology has a total shareholder equity of CN¥2.5B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 96.3%. Its total assets and total liabilities are CN¥5.7B and CN¥3.2B respectively. Jinhe Biotechnology's EBIT is CN¥197.4M making its interest coverage ratio 3. It has cash and short-term investments of CN¥842.0M.
Key information
96.3%
Debt to equity ratio
CN¥2.41b
Debt
| Interest coverage ratio | 3x |
| Cash | CN¥841.97m |
| Equity | CN¥2.51b |
| Total liabilities | CN¥3.23b |
| Total assets | CN¥5.74b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002688's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.9B).
Long Term Liabilities: 002688's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥1.4B).
Debt to Equity History and Analysis
Debt Level: 002688's net debt to equity ratio (62.7%) is considered high.
Reducing Debt: 002688's debt to equity ratio has increased from 70.6% to 96.3% over the past 5 years.
Debt Coverage: 002688's debt is not well covered by operating cash flow (16.9%).
Interest Coverage: 002688's interest payments on its debt are well covered by EBIT (3x coverage).